Injecting tirzepatide in the stomach area tends to be the most popular site due to ease of access and consistent absorption
Acute Pancreatitis Inform patients of the potential risk for acute pancreatitis and its symptoms: severe abdominal pain that sometimes radiates to the back, and which may or may not be accompanied by nausea or vomiting
Athletes and active individuals If you train seriously, nighttime injection has a clear advantage: your workouts happen during the day when you are furthest from any acute injection side effects
Pastries, donuts, processed cheeses, and packaged snack cakes often contain 40-50% calories from fat, making them particularly problematic during tirzepatide treatment
For those sourcing from other countries, our guide on tirzepatide in Mexico covers cross-border considerations
The GIP/GLP-1-receptor agonist tirzepatide was approved for the treatment of T2D by the Food and Drug Administration (FDA) in the USA for once-weekly subcutaneous injections in May 2022 and has just received a positive opinion from the European Medicines Agency (EMA)